THE Objective of This Contract IS to Develop a Second-Generation Assay for the Oraquick Ebola Rapid Antigen Test AS a Sustainable, Enhanced Test Including Alternative Reagents (antibody and Antigen) With Continued Availability, Extended Shelf-Life, a
Contract Overview
Contract Amount: $15,504,106 ($15.5M)
Contractor: Orasure Technologies Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2023-01-03
End Date: 2027-06-30
Contract Duration: 1,639 days
Daily Burn Rate: $9.5K/day
Official Description: THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EBOLA RAPID ANTIGEN TEST AS A SUSTAINABLE, ENHANCED TEST INCLUDING ALTERNATIVE REAGENTS (ANTIBODY AND ANTIGEN) WITH CONTINUED AVAILABILITY, EXTENDED SHELF-LIFE, A
Place of Performance
Location: Pennsylvania, 18015